Assays for determining plasma kallikrein system biomarkers
US11372002B2 · kind B2 · utility
1Cited by
12References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 17, 2014 |
| Grant date | Jun 28, 2022 |
| Priority date | — |
| Expiry date | Aug 24, 2036 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and assays for determining the activation level of the plasma kallikrein (pKal) system and the uses thereof for assessing the activity of pKal modulators on the pKal system.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.